Status:
COMPLETED
Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors
Lead Sponsor:
Noom Inc.
Conditions:
Weight Loss
Behavior, Health
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively de...
Eligibility Criteria
Inclusion
- Able to understand and provide informed consent
- 18 years and older
- Overweight or obesity (BMI ≥ 27.5)
- Not 6 months postpartum
- Not planning to become pregnant in the next 7 months
- Have a smartphone that is compatible with Noom's mobile app
- Breast cancer survivor with stage I, II, or III
- Completed active treatment (e.g, surgery, chemo, radiation, etc.) \> 6 months ago
Exclusion
- Inability or unwillingness of a participant to give written informed consent
- Currently pregnant or \< 6 months postpartum
- Plans to become pregnant within the next 7 months
- Stage IV, metastatic cancer or DCIS
- Currently taking insulin
- Uncontrolled hypertension
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04753268
Start Date
March 24 2021
End Date
October 1 2021
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Noom, Inc
New York, New York, United States, 10001